These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25995035)

  • 41. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
    Miettinen M; Wang Z; Lasota J; Heery C; Schlom J; Palena C
    Am J Surg Pathol; 2015 Oct; 39(10):1305-12. PubMed ID: 26099010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
    Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
    J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Morphological characteristics and prognostic criteria for gastrointestinal stromal tumors].
    Tsyganova IV; Anurova OA; Mazurenko NN
    Arkh Patol; 2011; 73(6):37-42. PubMed ID: 22379899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).
    Wei YC; Chou FF; Li CF; Li WM; Chen YY; Lan J; Li SH; Fang FM; Hu TH; Yu SC; Eng HL; Uen YH; Tian YF; Wang JC; Huang HY
    Histopathology; 2013 Oct; 63(4):445-54. PubMed ID: 23889148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.
    Jang BG; Lee HE; Kim WH
    Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysis.
    Perez D; Demartines N; Meier K; Clavien PA; Jungbluth A; Jaeger D
    J Invest Surg; 2007; 20(3):181-6. PubMed ID: 17613693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer.
    Pinto F; Pértega-Gomes N; Vizcaíno JR; Andrade RP; Cárcano FM; Reis RM
    Oncotarget; 2016 May; 7(20):28891-902. PubMed ID: 27049720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of age and gender on tumor related prognosis in gastrointestinal stromal tumors (GIST).
    Kramer K; Knippschild U; Mayer B; Bögelspacher K; Spatz H; Henne-Bruns D; Agaimy A; Schwab M; Schmieder M
    BMC Cancer; 2015 Feb; 15():57. PubMed ID: 25886494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exon 11 mutations, Ki67, and p16(INK4A) as predictors of prognosis in patients with GIST.
    Cerski MR; Pereira F; Matte US; Oliveira FH; Crusius FL; Waengertner LE; Osvaldt A; Fornari F; Meurer L
    Pathol Res Pract; 2011 Nov; 207(11):701-6. PubMed ID: 22024151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The GIST paradigm: how to establish diagnostic and prognostic criteria.
    Calabuig-Farinas S; Lopez-Guerrero JA; Llombart-Bosch A
    Arkh Patol; 2011; 73(4):13-21. PubMed ID: 22164425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.
    Cavnar MJ; Wang L; Balachandran VP; Antonescu CR; Tap WD; Keohan M; Singer S; Temple L; Nash GM; Weiser MR; Guillem JG; Aguilar JG; DeMatteo RP; Paty PB
    Ann Surg Oncol; 2017 Dec; 24(13):3972-3980. PubMed ID: 29058144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question.
    Lai BR; Wu YT; Kuo YC; Hsu HC; Chen JS; Chen TC; Wu RC; Chiu CT; Yeh CN; Yeh TS
    Oncotarget; 2016 Dec; 7(50):83270-83277. PubMed ID: 27806309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Study on Clinicopathological Features of Gastrointestinal Stromal Tumor and Relevant Prognostic Factors.
    Liu Q; Wang Y; Kong L; Kan Y
    Cell Biochem Biophys; 2015 Dec; 73(3):743-7. PubMed ID: 27259319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis.
    Kukar M; Kapil A; Papenfuss W; Groman A; Grobmyer SR; Hochwald SN
    J Surg Oncol; 2015 May; 111(6):696-701. PubMed ID: 25560251
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
    Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
    Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Machine learning based tissue analysis reveals Brachyury has a diagnosis value in breast cancer.
    Li K; Wang Q; Lu Y; Pan X; Liu L; Cheng S; Wu B; Song Z; Gao W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33734319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of biologic potential and risk stratification for predicting disease-free survival after resection of primary gastrointestinal stromal tumor: A multivariate clinicopathological study.
    Vij M; Agrawal V; Kumar A; Pandey R
    Indian J Cancer; 2015; 52(3):351-7. PubMed ID: 26905135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subgroups of patients with very large gastrointestinal stromal tumors with distinct prognoses: a multicenter study.
    Wada N; Kurokawa Y; Nishida T; Takahashi T; Toyokawa T; Kusanagi H; Hirota S; Tsujinaka T; Mori M; Doki Y
    J Surg Oncol; 2014 Feb; 109(2):67-70. PubMed ID: 24155204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.